Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Carleton

Showing results (91-100 of 108) with videos related to

Pageof 11
Sort By:
Plos One|August 8, 2013
A clinical tool for reducing central nervous system depression among neonates exposed to codeine through breast milkLauren E Kelly, Shahnaz A Chaudhry, Michael J Rieder, et al.
Pharmacoepidemiology and Drug Safety|March 14, 2021
Pharmacoepidemiology: A time for a new multidisciplinary approach to precision medicineAmalia M Issa, Bruce Carleton, Tobias Gerhard, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 26, 2023
Should secondary pharmacogenomic variants be actively screened and reported when diagnostic genome-wide sequencing is performed in a child?Jan M Friedman, Yvonne Bombard, Bruce Carleton, et al.
International Journal of Pediatric Otorhinolaryngology|July 20, 2014
Hearing loss in Mexican children treated with cisplatinOsvaldo D Castelán-Martínez, Ricardo Jiménez-Méndez, Felipe Rodríguez-Islas, et al.
Pediatrics|January 16, 2020
Big Data in the Assessment of Pediatric Medication SafetyAnn W McMahon, William O Cooper, Jeffrey S Brown, et al.
Plos One|September 20, 2022
The Canadian Mother-Child Cohort Active Surveillance Initiative (CAMCCO): Comparisons between Quebec, Manitoba, Saskatchewan, and AlbertaAnick Bérard, Padma Kaul, Sherif Eltonsy, et al.
Plos One|October 18, 2018
Incidence rates of narcolepsy diagnoses in Taiwan, Canada, and Europe: The use of statistical simulation to evaluate methods for the rapid assessment of potential safety issues on a population level in the SOMNIA studyCaitlin N Dodd, Maria de Ridder, Wan-Ting Huang, et al.
Pregnancy Hypertension|September 5, 2018
Activated protein C as disease-modifying therapy in antenatal preeclampsia: An open-label, single arm safety and efficacy trialPeter von Dadelszen, Laura A Magee, Samantha J Benton, et al.
Cancer|June 28, 2024
Roadmap for the next generation of Children's Oncology Group rhabdomyosarcoma trialsJonathan L Metts, Jamie M Aye, Jacquelyn N Crane, et al.
Canadian Journal of Kidney Health and Disease|November 25, 2021
A Canadian Study of Cisplatin Metabolomics and Nephrotoxicity (ACCENT): A Clinical Research ProtocolAnshika Jain, Ryan Huang, Jasmine Lee, et al.
Pageof 11

Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
Plos One|August 8, 2013
A clinical tool for reducing central nervous system depression among neonates exposed to codeine through breast milkLauren E Kelly, Shahnaz A Chaudhry, Michael J Rieder, et al.
Pharmacoepidemiology and Drug Safety|March 14, 2021
Pharmacoepidemiology: A time for a new multidisciplinary approach to precision medicineAmalia M Issa, Bruce Carleton, Tobias Gerhard, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 26, 2023
Should secondary pharmacogenomic variants be actively screened and reported when diagnostic genome-wide sequencing is performed in a child?Jan M Friedman, Yvonne Bombard, Bruce Carleton, et al.
International Journal of Pediatric Otorhinolaryngology|July 20, 2014
Hearing loss in Mexican children treated with cisplatinOsvaldo D Castelán-Martínez, Ricardo Jiménez-Méndez, Felipe Rodríguez-Islas, et al.
Pediatrics|January 16, 2020
Big Data in the Assessment of Pediatric Medication SafetyAnn W McMahon, William O Cooper, Jeffrey S Brown, et al.
Plos One|September 20, 2022
The Canadian Mother-Child Cohort Active Surveillance Initiative (CAMCCO): Comparisons between Quebec, Manitoba, Saskatchewan, and AlbertaAnick Bérard, Padma Kaul, Sherif Eltonsy, et al.
Plos One|October 18, 2018
Incidence rates of narcolepsy diagnoses in Taiwan, Canada, and Europe: The use of statistical simulation to evaluate methods for the rapid assessment of potential safety issues on a population level in the SOMNIA studyCaitlin N Dodd, Maria de Ridder, Wan-Ting Huang, et al.
Pregnancy Hypertension|September 5, 2018
Activated protein C as disease-modifying therapy in antenatal preeclampsia: An open-label, single arm safety and efficacy trialPeter von Dadelszen, Laura A Magee, Samantha J Benton, et al.
Cancer|June 28, 2024
Roadmap for the next generation of Children's Oncology Group rhabdomyosarcoma trialsJonathan L Metts, Jamie M Aye, Jacquelyn N Crane, et al.
Canadian Journal of Kidney Health and Disease|November 25, 2021
A Canadian Study of Cisplatin Metabolomics and Nephrotoxicity (ACCENT): A Clinical Research ProtocolAnshika Jain, Ryan Huang, Jasmine Lee, et al.
Pageof 11